After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a result—a condition that impacts 6.8 million Americans and carries a high ...

One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia. "We didn't know that we ...

AI researcher Nate Soares explains the Pentagon’s threats against Anthropic over the company’s AI guardrails. Morgan Neville shares a new side of Paul McCartney in his documentary “Man on the Run.” Dr ...

The iconic Irish traditional music band Dervish have landed a major TV deal with American broadcaster PBS. It was a milestone moment last December in the storied career of the legendary Sligo-based ...

A room on the fifth floor of the Central Arkansas Library System's main branch was packed Thursday night with members of Friends of PBS, a new citizen-led group aimed at keeping Public Broadcasting ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

CRISPR Therapeutics AG is commercially validated with CASGEVY but remains financially unproven and operates at a loss despite strong cash reserves. Incremental buying is attractive now for patient ...

LITTLE ROCK, Arkansas — Friends of Arkansas PBS is set to host a conversation in downtown Little Rock this week. The group is a citizen-led, grassroots advocacy coalition that was formed to keep PBS ...

Gene editing is a numbers game. For any genetic tweaks to have notable impact, a sufficient number of targeted cells need to have the disease-causing gene deleted or replaced. Despite a growing ...

Friends of Arkansas PBS, a newly formed, citizen-led group that hopes to preserve programming from the national Public Broadcasting Service in Arkansas, is hosting its first talk on Thursday. Former ...

CRISPR Therapeutics’ fourth quarter was relatively disappointing. As a biotech start-up still in its infancy though, these early quarterly numbers don’t mean much. The foreseeable future looks bright ...

A leading exec at the public broadcasting institution breaks down the impact of recent government cuts and what to do about them By Abbey White Associate Editor & News Writer In May 1969, Fred ...